Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 25 of 3173 entries
View as:

Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

Phase: N/A Priority: Normal
NCT ID: NCT04585815 Org: User:
Start: 11/10/20 End: 10/29/24 Due: 10/29/25

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03915951 Org: User:
Start: 06/04/19 End: 10/30/25 Due: 10/30/26

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Phase: N/A Priority: Normal
NCT ID: NCT00043368 Org: User:
Start: 09/30/02 End: 06/30/07 Due: 06/30/08

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00498602 Org: User:
Start: 11/30/07 End: 02/28/13 Due: 02/28/14

Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT00770289 Org: User:
Start: 05/31/08 End: 12/31/09 Due: 12/31/10

A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Phase: N/A Priority: Normal
NCT ID: NCT06546553 Org: User:
Start: 09/06/24 End: 10/21/25 Due: 10/21/26

Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT00888576 Org: User:
Start: 12/31/08 End: 12/31/11 Due: 12/31/12

A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01287897 Org: User:
Start: 02/28/11 End: 02/28/15 Due: 02/28/16

Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

Phase: N/A Priority: Normal
NCT ID: NCT00810407 Org: User:
Start: 11/30/08 End: 07/31/16 Due: 07/31/17

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00139659 Org: User:
Start: 01/31/03 End: 10/31/08 Due: 10/31/09

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00220402 Org: User:
Start: 07/31/04 End: 07/31/07 Due: 07/31/08

Lorlatinib - PF-06463922

Phase: N/A Priority: Normal
NCT ID: NCT03127618 Org: User:
Start: - End: - Due: -

A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00303498 Org: User:
Start: 03/27/06 End: 05/01/08 Due: 05/01/09

Drug Use Investigation of COMIRNATY Intramuscular Injection

Phase: N/A Priority: Normal
NCT ID: NCT04815031 Org: User:
Start: 03/20/21 End: 01/27/23 Due: 01/27/24

Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase

Phase: N/A Priority: Normal
NCT ID: NCT02667223 Org: User:
Start: 02/29/16 End: 07/31/16 Due: 07/31/17

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

Phase: N/A Priority: Normal
NCT ID: NCT03831880 Org: User:
Start: 02/07/19 End: 08/28/20 Due: 08/28/21

A Single Dose Study Of PF-06678552 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01992614 Org: User:
Start: 12/31/13 End: 03/31/14 Due: 03/31/15

A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05568407 Org: User:
Start: 01/18/23 End: 06/16/23 Due: 06/16/24

Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.

Phase: N/A Priority: Normal
NCT ID: NCT00367653 Org: User:
Start: 11/30/06 End: 09/30/07 Due: 09/30/08

Post Marketing Surveillance Study of Champix in Smoking Cessation for Filipino Patients

Phase: N/A Priority: Normal
NCT ID: NCT00794365 Org: User:
Start: 07/31/08 End: 11/30/09 Due: 11/30/10

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00580125 Org: User:
Start: 11/30/07 End: 09/30/08 Due: 09/30/09

Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03271047 Org: User:
Start: 10/18/17 End: 02/25/21 Due: 02/25/22

Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive

Phase: N/A Priority: Normal
NCT ID: NCT02792504 Org: User:
Start: 03/29/16 End: 07/22/20 Due: 07/22/21

A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04040192 Org: User:
Start: 09/12/19 End: 01/19/22 Due: 01/19/23

Glasdegib Absolute Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT03270878 Org: User:
Start: 09/07/17 End: 10/30/17 Due: 10/30/18